The bills, which have advanced in the Senate, would require schools to take certain preventative measures to protect student ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

This is a legal — and common — practice for many medications. Most type 2 diabetes injections for weight loss are glucagon-like peptide-1 (GLP-1) receptor agonists. These drugs mimic the GLP-1 ...

Serious hypersensitivity reactions have been reported with glucagon, including generalized ... once-weekly subcutaneous injection for hypothyroidism, as well as multiple early-stage programs ...